Hypotestosteronaemia in the aging male: should we treat it?

Minimal hepatic encephalopathy. Should we treat it?

Hepatic encephalopathy is an alteration of the central nervous system as a result of hepatic insufficiency after the exclusion of other known causes, and occurs in patients with cirrhosis, acute hepatic failure or portacaval shunts.1 It is characterized by a range of different neuropsychiatric disturbances that can include impairment of the sleep-wake cycle, cognition, memory, consciousness, pe...

Should we treat pyrexia? And how do we do it?

The concept of pyrexia as a protective physiological response to aid in host defence has been challenged with the awareness of the severe metabolic stress induced by pyrexia. The host response to pyrexia varies, however, according to the disease profile and severity and, as such, the management of pyrexia should differ; for example, temperature control is safe and effective in septic shock but ...

Early psoriatic arthritis: should we treat it in the same way as we treat rheumatoid arthritis?

2015 Joint damage predicts functional limitation and mortality in psoriatic arthritis patients, but evidence from cohort studies supports the idea that early diagnosis and treatment are beneficial. Given the revolution in the treatment of rheumatoid arthritis, treating to targets and close control have become attractive concepts in the clinical management of psoriatic arthritis. The evidence in...

Erythema nodosum :what should we consider about it?

Should we treat tuberculin converters.

Should we or should we not treat primary tuberculosis? Answers to this question have gone from one extreme, that we should treat them all with preventorium care, to the other extreme, that none of them should be treated because those who had sanitorium care did no better than those who had none. Now that we have antituberculous drugs of relatively low toxicity, this same question has come up ag...